- $33.9 BnWorld market, 2023
- $120.3 BnProjected, 2033
- 13.5%Growth a year (CAGR)
- 587Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$14.2 Bn
11.5% a year · 42% of the world -
2
China
$2.7 Bn
15% a year · 8% of the world -
3
Canada
$2.7 Bn
13.5% a year · 8% of the world -
4
Japan
$2.1 Bn
14% a year · 6.2% of the world -
5
Germany
$1.2 Bn
11.7% a year · 3.7% of the world -
6
France
$932 Mn
12.5% a year · 2.7% of the world -
7
UK
$881 Mn
11.5% a year · 2.6% of the world -
8
Brazil
$848 Mn
14.5% a year · 2.5% of the world -
9
Italy
$814 Mn
13% a year · 2.4% of the world -
10
Ecuador
$678 Mn
14.1% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Cannabis by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $33.9 Bn | $120.3 Bn | 13.5% | – | 587 | Report on Cannabis in Global |
| North America | $17 Bn | $55 Bn | 12.5% | 50% | 389 | Report on Cannabis in North America |
| APAC | $7.1 Bn | $28.2 Bn | 14.8% | 21% | 20 | Report on Cannabis in APAC |
| Europe | $6.4 Bn | $20.4 Bn | 12.2% | 19% | 88 | Report on Cannabis in Europe |
| Latin America | $1.5 Bn | $5.9 Bn | 14.5% | 4.5% | 12 | Report on Cannabis in Latin America |
| Middle East | $1.4 Bn | $5.3 Bn | 14.5% | 4% | 0 | Report on Cannabis in Middle East |
| Africa | $509 Mn | $2.1 Bn | 15% | 1.5% | 5 | Report on Cannabis in Africa |
| US |
$14.2 Bn | $42.3 Bn | 11.5% | 42% | 323 | Report on Cannabis in US |
| China |
$2.7 Bn | $11 Bn | 15% | 8% | 5 | Report on Cannabis in China |
| Canada |
$2.7 Bn | $9.6 Bn | 13.5% | 8% | 69 | Report on Cannabis in Canada |
| Japan |
$2.1 Bn | $7.8 Bn | 14% | 6.2% | 0 | Report on Cannabis in Japan |
| Germany |
$1.2 Bn | $3.8 Bn | 11.7% | 3.7% | 14 | Report on Cannabis in Germany |
| France |
$932 Mn | $3 Bn | 12.5% | 2.7% | 49 | Report on Cannabis in France |
| UK |
$881 Mn | $2.6 Bn | 11.5% | 2.6% | 12 | Report on Cannabis in UK |
| Brazil |
$848 Mn | $3.3 Bn | 14.5% | 2.5% | 9 | Report on Cannabis in Brazil |
| Italy |
$814 Mn | $2.8 Bn | 13% | 2.4% | 10 | Report on Cannabis in Italy |
| Ecuador |
$678 Mn | $2.5 Bn | 14.1% | 2% | 0 | Report on Cannabis in Ecuador |
 Spain |
$654 Mn | $2.1 Bn | 12.5% | 1.9% | 12 | Report on Cannabis in Spain |
 India |
$617 Mn | $2.8 Bn | 16.5% | 1.8% | 1 | Report on Cannabis in India |
 Saudi Arabia |
$576 Mn | $2.3 Bn | 15% | 1.7% | 0 | Report on Cannabis in Saudi Arabia |
 Mexico |
$509 Mn | $1.8 Bn | 13.8% | 1.5% | 3 | Report on Cannabis in Mexico |
 Australia |
$407 Mn | $1.6 Bn | 15% | 1.2% | 9 | Report on Cannabis in Australia |
 South Africa |
$220 Mn | $871 Mn | 14.7% | 0.6% | 2 | Report on Cannabis in South Africa |
 UAE |
$170 Mn | $657 Mn | 14.5% | 0.5% | 0 | Report on Cannabis in UAE |
 Egypt |
$95 Mn | $384 Mn | 15% | 0.3% | 3 | Report on Cannabis in Egypt |
 Philippines |
$75 Mn | $277 Mn | 14% | 0.2% | 0 | Report on Cannabis in Philippines |
 Malaysia |
$55 Mn | $197 Mn | 13.7% | 0.2% | 0 | Report on Cannabis in Malaysia |
 Hong Kong |
$54 Mn | $210 Mn | 14.5% | 0.2% | 3 | Report on Cannabis in Hong Kong |
 Singapore |
$41 Mn | $152 Mn | 14.1% | 0.1% | 0 | Report on Cannabis in Singapore |
 Thailand |
$41 Mn | $149 Mn | 13.8% | 0.1% | 2 | Report on Cannabis in Thailand |
 Kenya |
$24 Mn | $93 Mn | 14.6% | 0.1% | 0 | Report on Cannabis in Kenya |
 New Zealand |
– | – | – | – | 1 | Report on Cannabis in New Zealand |
 Russia |
– | – | – | – | 0 | Report on Cannabis in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 11,236 papers since 2021
- Assessment of Δ(9)-tetrahydrocannabiphorol (THCP), Δ(8)-tetrahydrocannabinol (Δ(8)-THC), and cannabinol (CBN) pharmacodynamics and pharmacokinetics across multiple routes of administration in the C57BL/6 mouse. European journal of pharmacology, 2026
- [Research Progress in Pharmacodynamics and Pharmacokinetics of Indole and Indazole-3-Carboxamide Synthetic Cannabinoids]. Fa yi xue za zhi, 2026
- [Qualitative Analysis of the Novel Synthetic Cannabinoid AFUBIATA]. Fa yi xue za zhi, 2026
- Cannabis sativa and the endocannabinoid system in cervical cancer: molecular targets and mechanistic insights from preclinical models-narrative review. Journal of cannabis research, 2026
- Neurogenic Pulmonary Edema in a 22-Year-Old Male Secondary to a Ruptured Cerebellar Arteriovenous Malformation: A Case Report. Cureus, 2026
Compare Cannabis side by side
Key companies in Cannabis
Curaleaf Holdings, Inc.
BYND Cannasoft Enterprises Inc.
Quick answers
How big is the Cannabis market?
The world Cannabis market was worth about $33.9 Bn in 2023 and is projected to reach $120.3 Bn by 2033, growing 13.5% a year (CAGR).
Which country has the largest Cannabis market?
The US is the largest of the 24 countries we cover, at $14.2 Bn in 2023. India grows fastest, at 16.5% a year.
How many clinical trials are running in Cannabis?
ClinicalTrials.gov lists 587 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Cannabis?
PubMed lists about 11,236 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.